Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
334,705,968
-
Total 13F shares
-
3,730
-
Share change
-
+3,730
-
Total reported value
-
$57,442
-
Price per share
-
$15.40
-
Number of holders
-
1
-
Value change
-
+$57,442
-
Number of buys
-
1
Institutional Holders of Telix Pharmaceuticals Ltd - Ordinary Shares (TLX) as of Q4 2024
As of 31 Dec 2024,
Telix Pharmaceuticals Ltd - Ordinary Shares (TLX) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
3,730 shares.
The largest 1 holders included
UBS Group AG.
This page lists
1
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.